AnaptysBio
ANAB
ANAB
116 hedge funds and large institutions have $441M invested in AnaptysBio in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 37 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 121 → 116 (-5)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
31% less call options, than puts
Call options by funds: $2.44M | Put options by funds: $3.52M
Holders
116
Holding in Top 10
6
Calls
$2.44M
Puts
$3.52M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$15.1M | |
| 3 | +$10.6M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$10.5M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$6.32M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$7.69M | |
| 3 | -$7.07M | |
| 4 |
Millennium Management
New York
|
-$5.69M |
| 5 |
Goldman Sachs
New York
|
-$2.75M |